ATE511395T1 - Mittel zur behandlung von glomerulopathie - Google Patents
Mittel zur behandlung von glomerulopathieInfo
- Publication number
- ATE511395T1 ATE511395T1 AT02720493T AT02720493T ATE511395T1 AT E511395 T1 ATE511395 T1 AT E511395T1 AT 02720493 T AT02720493 T AT 02720493T AT 02720493 T AT02720493 T AT 02720493T AT E511395 T1 ATE511395 T1 AT E511395T1
- Authority
- AT
- Austria
- Prior art keywords
- glomerular
- glomerulopathy
- agents
- treatment
- preventive
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D215/14—Radicals substituted by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2001121058 | 2001-04-19 | ||
| JP2001361257 | 2001-11-27 | ||
| PCT/JP2002/003870 WO2002085363A1 (fr) | 2001-04-19 | 2002-04-18 | Agent therapeutique pour soigner la maladie glomerulaire |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE511395T1 true ATE511395T1 (de) | 2011-06-15 |
Family
ID=26613829
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02720493T ATE511395T1 (de) | 2001-04-19 | 2002-04-18 | Mittel zur behandlung von glomerulopathie |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US7504415B2 (de) |
| EP (1) | EP1386608B1 (de) |
| JP (1) | JP4235000B2 (de) |
| AT (1) | ATE511395T1 (de) |
| PT (1) | PT1386608E (de) |
| WO (1) | WO2002085363A1 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT1386608E (pt) | 2001-04-19 | 2011-07-26 | Kowa Co | Agente terapêutico para doença glomerular |
| MY131170A (en) * | 2002-03-28 | 2007-07-31 | Nissan Chemical Ind Ltd | Therapeutic agent for glomerular disease |
| KR20070074576A (ko) * | 2004-10-29 | 2007-07-12 | 코와 가부시키가이샤 | 사구체 질환 치료제 |
| WO2008082537A2 (en) | 2006-12-19 | 2008-07-10 | The General Hospital Corporation | Compounds for modulating integrin cd11b/cd18 |
| ES2766751T3 (es) | 2012-04-20 | 2020-06-15 | Gb006 Inc | Composiciones para la regulación de integrinas |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2569746B2 (ja) * | 1987-08-20 | 1997-01-08 | 日産化学工業株式会社 | キノリン系メバロノラクトン類 |
| CA1336714C (en) * | 1987-08-20 | 1995-08-15 | Yoshihiro Fujikawa | Quinoline type mevalonolactone inhibitors of cholesterol biosynthesis |
| CA2052014A1 (en) * | 1990-10-19 | 1992-04-20 | Henry Y. Pan | Method for preventing diabetic complications employing a cholesterol lowering drug alone or in combination with an ace inhibitor |
| JPH08198898A (ja) * | 1995-01-30 | 1996-08-06 | Takeda Chem Ind Ltd | コレステロール搬出促進物質 |
| US6090839A (en) * | 1996-12-23 | 2000-07-18 | Merck & Co., Inc. | Antidiabetic agents |
| US6147109A (en) | 1997-10-14 | 2000-11-14 | The General Hospital Corporation | Upregulation of Type III endothelial cell Nitric Oxide Synthase by HMG-CoA reductase inhibitors |
| BR0109966A (pt) * | 2000-04-12 | 2003-08-05 | Novartis Ag | Combinação de compostos orgânicos |
| US6620821B2 (en) * | 2000-06-15 | 2003-09-16 | Bristol-Myers Squibb Company | HMG-CoA reductase inhibitors and method |
| AU2001284413A1 (en) * | 2000-08-30 | 2002-03-13 | Sankyo Company Limited | Medicinal compositions for preventing or treating heart failure |
| CA2424060A1 (en) * | 2000-10-12 | 2003-03-31 | Nissan Chemical Industries, Ltd. | Preventives and remedies for complications of diabetes |
| PT1386608E (pt) | 2001-04-19 | 2011-07-26 | Kowa Co | Agente terapêutico para doença glomerular |
-
2002
- 2002-04-18 PT PT02720493T patent/PT1386608E/pt unknown
- 2002-04-18 EP EP02720493A patent/EP1386608B1/de not_active Expired - Lifetime
- 2002-04-18 WO PCT/JP2002/003870 patent/WO2002085363A1/ja active Application Filing
- 2002-04-18 US US10/474,194 patent/US7504415B2/en not_active Expired - Fee Related
- 2002-04-18 JP JP2002582936A patent/JP4235000B2/ja not_active Expired - Fee Related
- 2002-04-18 AT AT02720493T patent/ATE511395T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| US7504415B2 (en) | 2009-03-17 |
| EP1386608A1 (de) | 2004-02-04 |
| EP1386608A4 (de) | 2005-02-09 |
| EP1386608B1 (de) | 2011-06-01 |
| WO2002085363A1 (fr) | 2002-10-31 |
| JP4235000B2 (ja) | 2009-03-04 |
| JPWO2002085363A1 (ja) | 2004-08-05 |
| PT1386608E (pt) | 2011-07-26 |
| US20040116468A1 (en) | 2004-06-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA03011484A (es) | Heteroarilos multiciclicos sustituidos con quinuclidinas para el tratamiento de enfermedades. | |
| CY1111951T1 (el) | Φαινυλο-καρβοξαμιδικες ενωσεις χρησιμες για την αντιμετωπιση πονου | |
| EA200201247A1 (ru) | Соединения для лечения болезни альцгеймера | |
| CY1110969T1 (el) | 5-υποκατεστημενα-2-φαινυλαμινο-βενζαμιδια ως αναστολεiς μεκ | |
| ATE272398T1 (de) | Verwendung von ep4 rezeptorliganden zur behandlung von neuropathischen schmerz | |
| EA200401114A2 (ru) | Замещённые гидроксиэтиламины | |
| ATE389395T1 (de) | Substituierte 2-aminotetraline zur vorbeugenden behandlung von morbus parkinson | |
| DK1458393T3 (da) | Substituerede diketopiperaziner som oxytocinantagonister | |
| DE69834500D1 (de) | Xanthinderivative zur behandlung von hirnischämie | |
| ATE366107T1 (de) | Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen | |
| ATE550039T1 (de) | Mittel zur behandlung von glomerulären erkrankungen | |
| DE60002558D1 (de) | Derivate der Phosphonsäure zur Inhibierung von Carboxypeptidase B | |
| ATE511395T1 (de) | Mittel zur behandlung von glomerulopathie | |
| EP1256581A4 (de) | Vorbeugende oder therapeutische mittel für gastriche oder ösophageale regurgitation | |
| IL150965A0 (en) | Therapeutic or preventive agent for digestive system diseases containing a diaminotrifluoromethylpyridine derivative | |
| KR970706811A (ko) | I형 알레르기성 질환의 예방 및 치료제(Preventive and remedy for type Ⅰ allergic diseases) | |
| ATE332697T1 (de) | Cyanidinmischung zur behandlung von dickdarmkrebs | |
| DK1174131T3 (da) | Anvendelse af et middel til forbedring af astrocytfunktion til behandling af Parkinsons sygdom | |
| ATE305783T1 (de) | Verwendung von diaminotrifluoromethylpyridinderivaten für die prevention und behandlung von lebererkrankungen | |
| BR0214780A (pt) | Sal de ácido cìtrico de um composto terapêutico e composições farmacêuticas deste | |
| EP1325918A4 (de) | Herzmuskelzellen-apoptose hemmstoffe und behandlung/vorbeugung von herzkrankheiten | |
| DE60143671D1 (de) | Behandlung von neuropathischen schmerzen mittels eines n-methyl-d-aspartate (nmda)-rezeptor-antagonists | |
| ATE359778T1 (de) | Mittel zur behandlung von myelopathie | |
| TH51180A (th) | วิธีสำหรับการรักษาโรคพาร์คินสันโดยการให้ (-)-5- คีโท-2-N,N-ได-n-โปรพิลอะมิโน-เตตระไฮโดรเตตระลิน | |
| ATE360432T1 (de) | Peptid zur behandlung von nervenerkrankungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |